| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/22/2010 | US20100098685 Use of Inhibitors of Toll-Like Receptors in the Prevention and Treatment of Hypercholesterolemia and Hyperlipidemia and Diseases Related Thereto |
| 04/22/2010 | US20100098684 Biomarkers and methods for detecting and treating spinal and joint pain |
| 04/22/2010 | US20100098683 MUC1 and Galectin-3 |
| 04/22/2010 | US20100098682 Effect of Bri Proteins on Ass Production |
| 04/22/2010 | US20100098681 Dimeric high affinity egfr constructs and uses thereof |
| 04/22/2010 | US20100098680 Anti-pathogen treatments |
| 04/22/2010 | US20100098679 Promotion of peroxisomal catalase function in cells |
| 04/22/2010 | US20100098677 Methods and Devices for Epithelial Protection During Photodynamic Therapy |
| 04/22/2010 | US20100098676 Synergistic anti-inflammatory and antioxidant dietary supplement compositions |
| 04/22/2010 | US20100098671 composition for prevention or treatment of bone marrow damage |
| 04/22/2010 | US20100098662 Treatment of liver diseases in which iron plays a role in pathogenesis |
| 04/22/2010 | US20100098661 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 04/22/2010 | US20100098660 Method of treating tuberculosis with interferons |
| 04/22/2010 | US20100098659 Compositions and methods for treating matrix metalloproteinase 9 (mmp9)-mediated conditions |
| 04/22/2010 | US20100098658 Biopolymer Conjugates Comprising an Interleukin-11 Analog |
| 04/22/2010 | US20100098657 Method of Treating Cancer with Immunomodulatory Compounds and IgG |
| 04/22/2010 | US20100098656 Polyamino acids functionalized by hydrophobic grafts bearing an anionic charge and applications thereof, such as therapeutic applications |
| 04/22/2010 | US20100098645 Formulation and method for the treatment of fungal nail infections |
| 04/22/2010 | US20100098638 RIP140 Regulation of Diabetes |
| 04/22/2010 | US20100098636 Compositions for Delivery of Therapeutics and Other Materials |
| 04/22/2010 | US20100098630 Phenazine and Quinoxaline Substituted Amino Acids and Polypeptides |
| 04/22/2010 | US20100098628 Proteins |
| 04/22/2010 | US20100098627 Proteins |
| 04/22/2010 | US20100098626 Protein |
| 04/22/2010 | US20100098625 Icbp90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
| 04/22/2010 | US20100098624 Method for using cdo antagonists to modulate hedgehog signaling |
| 04/22/2010 | DE10324256B4 Lipid-Tranferprotein-Systeme und deren kosmetische/dermatologische Anwendung Lipid Tranferprotein systems and their cosmetic / dermatological use |
| 04/22/2010 | DE102008051834A1 Drug, useful e.g. for treating diabetes, preferably type-I or II and for controlling fasting, postprandial and/or postabsorptive plasma glucose concentration, comprises insulin and glucagon-like peptide-1 agonist |
| 04/22/2010 | CA2805888A1 Whey protein compostions, methods and uses |
| 04/22/2010 | CA2777486A1 Methods and compositions for treatment of myotonic dystrophy |
| 04/22/2010 | CA2741065A1 Muc-1 cytoplasmic domain peptides as inhibitors of cancer |
| 04/22/2010 | CA2740989A1 Compositions and methods for treatment of kidney disorders |
| 04/22/2010 | CA2740871A1 Biomarkers and methods for detecting and treating spinal and joint pain |
| 04/22/2010 | CA2740762A1 Method of protecting cells |
| 04/22/2010 | CA2740685A1 Combination of an insulin and a glp-1 agonist |
| 04/22/2010 | CA2740557A1 Annexin and its use to treat inflammatory disorders |
| 04/22/2010 | CA2740316A1 Conjugates of glp-1 agonists and uses thereof |
| 04/22/2010 | CA2738757A1 Pharmaceutical compositions and methods of use for the prevention and treatment of hypoxic injury |
| 04/22/2010 | CA2738715A1 Highly concentrated drug particles, formulations, suspensions and uses thereof |
| 04/22/2010 | CA2708674A1 Compositions for the prevention and treatment of neuroinjury and methods of use thereof |
| 04/21/2010 | EP2177620A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/21/2010 | EP2177619A1 HSV strains for the oncolytic treatment of cancer |
| 04/21/2010 | EP2177616A1 Soluble zcytor 11 cytokine receptors |
| 04/21/2010 | EP2177534A2 Heteroclitic analogs of class i epitopes |
| 04/21/2010 | EP2177533A1 Multiple N-methylated cyclic hexapeptides for treatment of neurogenic inflammation |
| 04/21/2010 | EP2177530A1 Octapeptide having antiangiogenic activity |
| 04/21/2010 | EP2177529A1 Novel -secretase inhibitor |
| 04/21/2010 | EP2177231A2 Use of goat serum for veterinary treatment |
| 04/21/2010 | EP2177228A1 DNA vaccination for treatment of autoimmune disease |
| 04/21/2010 | EP2177227A1 Use of hyaluronidase for the prevention or treatment of arterial hypertension or cardiac insufficiency |
| 04/21/2010 | EP2177223A2 Homoharringonine alone or combined with other agents for use in treating chronic myelogenous leukemia resistant or intolerant to sti571 |
| 04/21/2010 | EP2176665A1 Tumor cell-derived microvesicles |
| 04/21/2010 | EP2176413A1 Immunology treatment for biofilms |
| 04/21/2010 | EP2176288A2 Tnf superfamily collectin fusion proteins |
| 04/21/2010 | EP2175879A1 Treatment of prion protein related diseases |
| 04/21/2010 | EP2175876A1 Agents containing proteases from stenotrophomonas maltophilia |
| 04/21/2010 | EP2175875A2 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof |
| 04/21/2010 | EP2175874A2 Use of peptidic vasopressin receptor agonists |
| 04/21/2010 | EP2175873A2 Treatment for anxiety |
| 04/21/2010 | EP2175872A2 Thrombomodulin for increasing reperfusion and preventing blood vessels obstruction |
| 04/21/2010 | EP2175869A1 Repair of lesions in cartilage and bone using a chondro-regulative matrix |
| 04/21/2010 | EP2175865A2 Controlled release interferon drug products and treatment of hcv infection using same |
| 04/21/2010 | EP2175864A2 Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages |
| 04/21/2010 | EP2175841A1 Osteopontin nanoparticles system for drug delivery |
| 04/21/2010 | EP2175834A2 Glp-1-fc fusion protein formulation |
| 04/21/2010 | EP1791858B1 Modified vp1-capsid protein of parvovirus b19 |
| 04/21/2010 | EP1730174B1 Peptide carrier for drug delivery |
| 04/21/2010 | EP1716232B1 Acid alpha-glucosidase and fragments thereof |
| 04/21/2010 | EP1635692B1 Monitoring immunologic, hematologic and inflammatory diseases |
| 04/21/2010 | EP1594960B1 Human cyclooxygenase-3 and uses thereof |
| 04/21/2010 | EP1549957B1 Method for determining the susceptibility of a subject to infection |
| 04/21/2010 | EP1519945B1 Novel chemokine binding peptides capable of modulating the biological activity of chemokines |
| 04/21/2010 | EP1325113B1 Factor vii glycoforms |
| 04/21/2010 | EP1323730B1 Novel polypeptides and anti-hiv drugs containing the same |
| 04/21/2010 | EP1231930B1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS |
| 04/21/2010 | EP0922102B1 Hepatocyte growth factor receptor agonists and uses thereof |
| 04/21/2010 | EP0870033B1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 04/21/2010 | CN1978462B Imidazoline modified amino acid, and its synthesizing method and use for polypeptide marking |
| 04/21/2010 | CN1785153B Nano-grade material preparation apparatus, and method for preparing nano-anti-oxidation active poly peptide medicine |
| 04/21/2010 | CN1711096B Botulinum toxin formulations for oral administration |
| 04/21/2010 | CN1639318B Antimicrobial composition |
| 04/21/2010 | CN101696240A Long lasting growth hormone releasing factor derivatives |
| 04/21/2010 | CN101696234A Polypeptide for resisting rheumatoid arthritis and application thereof in pharmacy |
| 04/21/2010 | CN101696232A Peptidomimetic protease inhibitors |
| 04/21/2010 | CN101695574A Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 04/21/2010 | CN101695374A Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 04/21/2010 | CN101240026B Conjugate constructed from normal tridecyl and RGD peptide, and its synthesis and application in medicine |
| 04/21/2010 | CN101172161B Water-soluble polymers decorated G-CSF conjugates |
| 04/21/2010 | CN101062950B Polyethylene glycol modified thymus peptide 1 derivative |
| 04/20/2010 | USRE41252 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 04/20/2010 | US7702430 Method for designing a potential inhibitor of glutathione-aldehyde conjugate binding to aldose reductase |
| 04/20/2010 | US7700775 Drug delivery |
| 04/20/2010 | US7700765 DNA minor groove binding compounds |
| 04/20/2010 | US7700757 for treatment of chronic inflammatory bowel disease, Crohn's disease and ulcerative colitis |
| 04/20/2010 | US7700755 cytotoxins; host cells; vaccines; histology |
| 04/20/2010 | US7700749 Nucleic acid and corresponding protein entitled 205P1B5 useful in treatment and detection of cancer |
| 04/20/2010 | US7700748 VMGLOM gene and its mutations causing disorders with a vascular component |
| 04/20/2010 | US7700736 PRO350 antibodies |
| 04/20/2010 | US7700735 High potency recombinant antibodies and method for producing them |
| 04/20/2010 | US7700733 Factor VII or VIIa polypeptide variants |